IBB vs SDY
iShares Biotechnology ETF vs SPDR S&P Dividend ETF
- • SDY has the lower expense ratio at 0.35% vs 0.44% for IBB.
- • SDY pays a higher dividend yield (2.35%).
Side-by-side metrics
| Metric | IBB | SDY |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.16% | 2.35% |
AUM Assets under management — bigger funds are typically more liquid. | $11.50B | $23.87B |
YTD return | 30.22% | 19.71% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.60 | 0.48 |
P/E ratio | 25.48 | 18.98 |
Last price | $217.75 | $163.50 |
Inception | — | — |
Issuer | iShares | State Street |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
SDY top holdings
| ACN | Accenture PLC Class A | 4.02% |
| VZ | Verizon Communications Inc | 2.81% |
| CVX | Chevron Corp | 2.18% |
| O | Realty Income Corp | 1.91% |
| PEP | PepsiCo Inc | 1.84% |
| MDT | Medtronic PLC | 1.81% |
| TGT | Target Corp | 1.63% |
| ADP | Automatic Data Processing Inc | 1.53% |
| NKE | Nike Inc Class B | 1.52% |
| XOM | ExxonMobil Holdings Corp | 1.52% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About SDY
SDY (SPDR S&P Dividend ETF) is Highest-yielding S&P Composite 1500 dividend growers. Managed by State Street, the fund carries $23.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 2.35%. Its largest holding is Accenture PLC Class A (ACN), which represents 4.0% of the portfolio. Real Estate is the fund's largest sector exposure at 3.7%.